The value of periportal hyperintensity sign from gadobenate dimeglumine-enhanced hepatobiliary phase MRI for predicting clinical outcomes in patients with decompensated cirrhosis

Insights into Imaging

Table 3 Cox survival analysis for predicting death in patients with decompensated cirrhosis

Variables	Univariate			Multivariate
Variables	HR	95% CI	p value	HR	95% CI	p value
Age (years)	1.025	0.964–1.090	0.427
Sex (male)	1.386	0.372–5.160	0.627
Periportal hyperintensity sign on HBP	28.056	5.808–135.524	< 0.0001	23.677	4.759–117.788	0.0001
Periportal hyperintensity sign on T2WI	1.413	0.177–11.300	0.745
Aspartate aminotransferase (U/L)	1.000	0.990–1.010	0.933
Alanine transaminase (U/L)	0.999	0.992–1.007	0.868
Albumin (g/L)	1.040	0.947–1.143	0.413
PT	1.035	0.944–1.135	0.461
MELD score	1.184	1.078–1.302	0.0004	1.140	1.037–1.252	0.006

HR hazard ratio, CI confidence interval, PT prothrombin time, INR international normalized ratio, MELD model for end-stage liver disease